V0 screening: beyond the lung lump.
An international medical study has brought new findings and related findings are of important reference value for disease prevention. Low-dose CT lung cancer screening helps to reduce lung cancer mortality in high-risk individuals and in frequent clinically related accidental detections. In national lung screening trials, about one-third of CT screening results show other abnormalities besides lung cancer, which pose challenges in interpretation, reporting and further management.
Lack of consistent guidance and the clinical significance of these findings may hinder the widespread use of lung cancer screening. Occasional screening uses low-dose CT (LDCT) screening for the diagnosis of lung cancer to identify other serious conditions with additional seriousness without additional costs. The main findings in the chest include pneumonia, pulmonary disease, pulmonary disease, coronary artery disease, hip lymphoma.
It should be noted that the above information is based on international publicly available research and is not a diagnostic recommendation for healthcare. If you have any health questions, please consult a professional medical professional.
















